Stay updated on APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical trial record for a study of APX005M-based combinations in previously untreated metastatic pancreatic cancer is now displayed, including study design, eligibility criteria, outcomes, and supporting documents.SummaryDifference70%

- Check18 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0, with the study page still showing a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site’s footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error with the site header, navigation, and a revision footer. The extensive list of study documents and related metadata that previously appeared on the page is no longer shown.SummaryDifference21%

Stay in the know with updates to APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.